Trials that use: t-test
New to this method? Read the tutorial →
2,970 results
- NIRVANAIndependent statistical analysis of A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause: primary endpoint results, effect estimate with confidence…
- Nitroglycerin Infusion During Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nitroglycerin Infusion During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01901419).
- Nitrous Oxide for External Cephalic Version: Complete Statistical AnalysisIndependent statistical analysis of Nitrous Oxide for External Cephalic Version: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03502915).
- Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NMDA Antagonists in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of NMDA Antagonists in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01833897).
- NMDA Receptors in Motor Learning in Humans: Complete Statistical AnalysisIndependent statistical analysis of NMDA Receptors in Motor Learning in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082912).
- NO-ASPIRATEIndependent statistical analysis of Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02284178).
- no-cryIndependent statistical analysis of Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- No-POPPYIndependent statistical analysis of Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NOH303Independent statistical analysis of Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Non-DrinkerIndependent statistical analysis of Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma: primary endpoint…
- Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment: Complete Statistical AnalysisIndependent statistical analysis of Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04435769).
- Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Non-invasive Nerve Stimulation and Cognitive Training to Improve Cognitive Performance in Healthy Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Non-opioids for Analgesia After Adenotonsillectomy in Children: Complete Statistical AnalysisIndependent statistical analysis of Non-opioids for Analgesia After Adenotonsillectomy in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03618823).
- Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation: Complete Statistical AnalysisIndependent statistical analysis of Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00333619).
- Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261674).
- Noninvasive Modulation of Motivational Brain Regions in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Noninvasive Modulation of Motivational Brain Regions in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04972786).
- Noninvasive Spinal Stimulation in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Noninvasive Spinal Stimulation in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714282).
- NOSE-400Independent statistical analysis of A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOTABLeIndependent statistical analysis of Neuromodulation for Accidental Bowel Leakage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03278613).
- Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04447846).
- Novel Pharyngeal Metrics to Predict Dysphagia Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Novel Pharyngeal Metrics to Predict Dysphagia Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569097).
- NSAID Use in Postpartum Hypertensive Women: Complete Statistical AnalysisIndependent statistical analysis of NSAID Use in Postpartum Hypertensive Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02902172).
- NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: Complete Statistical AnalysisIndependent statistical analysis of NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03182374).
- NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: Complete Statistical AnalysisIndependent statistical analysis of NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669785).
- OARS-PilotIndependent statistical analysis of Opioid Analgesic Reduction Study (OARS) - Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05283499).
- OASIS Wound Matrix (Oasis) Mechanism of Action: Complete Statistical AnalysisIndependent statistical analysis of OASIS Wound Matrix (Oasis) Mechanism of Action: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570141).
- OASIS-1Independent statistical analysis of A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal…
- OASIS-4Independent statistical analysis of A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy…
- OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE): primary endpoint results, effect estimate with confidence…
- OASIS(CM)Independent statistical analysis of Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Obesity and Nonalcoholic Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Obesity and Nonalcoholic Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00262964).
- Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OCEANIndependent statistical analysis of Randomized Study of Obicetrapib in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04770389).
- Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression: Complete Statistical AnalysisIndependent statistical analysis of Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ODENIndependent statistical analysis of ODEN Trial: Option vs. Denali IVC Filters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201277).
- OIIndependent statistical analysis of Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OLIFIndependent statistical analysis of OptiMesh® for Lumbar Interbody Fusion Trial (OLIF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00764491).
- Olmesartan Comparison to Losartan in Hypertensive Subjects: Complete Statistical AnalysisIndependent statistical analysis of Olmesartan Comparison to Losartan in Hypertensive Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00949884).
- Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OLOLIndependent statistical analysis of Our Lifestyles Our Lives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02965729).
- Olopatadine Eye Drops and Allergy Skin Testing: Complete Statistical AnalysisIndependent statistical analysis of Olopatadine Eye Drops and Allergy Skin Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775658).
- Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy: Complete Statistical AnalysisIndependent statistical analysis of Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00511810).
- Omentectomy and Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Omentectomy and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00923260).